The Principles of Clinical Cytogenetics - Extra Materials - Springer

Cytogenetics of Hematologic Neoplasms 413
88. Pedersen-Bjergaard, J., Philip, P., Larsen, S.O., et al. (1993) Therapy-related myelodysplasia and acute myeloid leukemia.
Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for
malignant diseases in the Copenhagen series. 7, 1975–1986.
89. Pui, C.H., Relling, M.V., Rivera, G.K., et al. (1995) Epipodophyllotoxin-related acute myeloid leukemia: a study of 35
cases. Leukemia 9, 1990–1996.
90. Quesnel, B., Kantarjian, H., Bjergaard, J.P., et al. (1993) Therapy-related acute myeloid leukemia with t(8;21), inv(16),
and t(8;16): a report on 25 cases and review of the literature. J. Clin. Oncol. 11, 2370–2379.
91. Secker-Walker, L.M., Moorman, A.V., Bain, B.J., and Mehta, A.B. (1998) Secondary acute leukemia and myelodysplastic
syndrome with 11q23 abnormalities. Leukemia 12, 840–844.
92. Michels, S.D., McKenna, R.W., Arthur, D.C., and Brunning, R.D. (1985) Therapy-related acute myeloid leukemia and
myelodysplastic syndrome: a clinical and morphologic study of 65 cases. Blood 65, 1364–1372.
93. Venditti, A., Del Poeta, G., Stasi, R., et al. (1994) Minimally differentiated acute myeloid leukaemia (AML-M0):
cytochemical, immunophenotypic and cytogenetic analysis of 19 cases. Br. J. Haematol. 88, 784–793.
94. Stark, B., Resnitzky, P., Jeison, M., et al. (1995) A distinct subtype of M4/M5 acute myeloblastic leukemia (AML)
associated with t(8:16)(p11:p13), in a patient with the variant t(8:19)(p11:q13)—case report and review of the literature.
Leukemia Res. 19, 367–379.
95. Bernstein, J., Dastugue, N., Haas, O.A., et al. (2000) Nineteen cases of the t(1;22)(p13;q13) acute megakaryblastic
leukaemia of infants/children and a review of 39 cases: report from a t(1;22) study group. Leukemia 14, 216–218.
96. Murphy, S.B. (1978) Childhood non-Hodgkin’s lymphoma. N. Engl. J. Med. 299, 1446–1448.
97. Ries, L.A.G., Kosary, C.L., Hankey, B.F., Miller, B.A., Clegg, L., and Edwards, B.K. (1999). SEER Cancer Statistics
Review, 1973–1996, National Cancer Institute.
98. Sandler, D.P. and Ross, J.A. (1997) Epidemiology of acute leukemia in children and adults. Semin. Oncol. 24, 3–16.
99. Ries, L.A.G., Smith, M.A., Gurney, J.G., et al. (1995) Cancer incidence and survival among children and adolescents.
SEER Program 1975–1995, National Cancer Institute.
100. Navid, F., Mosijczuk, A.D., Head, D.R., et al. (1999) Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation
and FAB L3 morphology associated with a B-precursor immunophenotype: the Pediatric Oncology Group experience.
Leukemia 13, 135–141.
101. Raimondi, S.C. (1993) Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 81,
2237–2251.
102. Martin, P.L., Look, A.T., Schnell, S., et al. (1996) Comparison of fluorescence in situ hybridization, cytogenetic analysis,
and DNA index analysis to detect chromosomes 4 and 10 aneuploidy in pediatric acute lymphoblastic leukemia: a
Pediatric Oncology Group study. J. Pediatr. Hematol. Oncol. 18, 113–121.
103. Lange, B.J. (2000) The ultra low risk child with acute lymphoblastic leukemia. In Education Program Book. American
Society of Hematology, Washington, DC, pp. 286–294.
104. Pilozzi, E., Muller-Hermelink, H.K., Falini, B., et al. (1999) Gene rearrangements in T-cell lymphoblastic lymphoma.
J. Pathol. 188, 267–270.
105. Okuda, T., Fisher, R., and Dwoning, J.R. (1996) Molecular diagnositcs in pediatric acute lymphoblastic leukemia. Mol.
Diagn. 1, 139–151.
106. Schneider, N.R., Carroll, A.J., Shuster, J.J., et al. (2000) New recurring cytogenetic abnormalities and association of
blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group
report of 343 cases. Blood 96, 2543–2549.
107. Anon. (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma.
The Non-Hodgkin’s Lymphoma Classification Project. Blood 89, 3909–3918.
108. Armitage, J.O. and Weisenburger, D.D. (1998) New approach to classifying non-Hodgkin’s lymphomas: clinical features
of the major histologic subtypes. J. Clin. Oncol. 16, 2780–2795.
109. Prevot, S., Hamilton-Dutoit, S., Audouin, J., Walter, P., Pallesen, G., and Diebold, J. (1992) Analysis of African
Burkitt’s and high-grade B cell non-Burkitt’s lymphoma for Epstein–Barr virus genomes using in situ hybridization.
Br. J. Haematol. 80, 27–32.
110. Rai, K.R., Sawitsky, A., Cronkite, E.P., Chanana, A.D., Levy, R.N., and Pasternack, B.S. (1975) Clinical staging of
chronic lymphocytic leukemia. Blood 46, 219–234.
111. Bizzozero, O.J., Jr., Johnson, K.G., and Ciocco, A. (1966) Radiation-related leukemia in Hiroshima and Nagasaki,
1946–1964. I. Distribution, incidence and appearance time. N. Engl. J. Med. 274, 1095–1101.
112. Ben-Ezra, J., Burke, J.S., Swartz, W.G., et al. (1989) Small lymphocytic lymphoma: a clinicopathologic analysis of 268
cases. Blood 73, 579–587.
113. Lennert, K. (1978) Malignant Lymphomas Other Than Hodgkin’s Disease. Springer-Verlag, New York.
114. Damle, R.N., Wasil, T., Fais, F., et al. (1999) Ig V gene mutation status and CD38 expression as novel prognostic
indicators in chronic lymphocytic leukemia. Blood 94, 1840–1847.
115. Dèohner, H., Stilgenbauer, S., Dèohner, K., Bentz, M., and Lichter, P. (1999) Chromosome aberrations in B-cell chronic
lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. J. Mol. Med. (Berlin) 77, 266–281.